Argulian Edgar, Borer Jeffrey S, Messerli Franz H
Division of Cardiology, Icahn School of Medicine, Mt Sinai St Luke's Hospital, New York, NY.
SUNY Downstate Medical Center, Brooklyn, NY.
Am J Med. 2016 Sep;129(9):919-23. doi: 10.1016/j.amjmed.2016.03.010. Epub 2016 Apr 5.
Mitral regurgitation is a common heart valve disease. It is defined to be primary when it results from the pathology of the mitral valve apparatus itself and secondary when it is caused by distortion of the architecture or function of the left ventricle. Although the diagnosis and management of mitral regurgitation rely heavily on echocardiography, one should bear in mind the caveats and shortcomings of such an approach. Clinical decision making commonly focuses on the indications for surgery, but it is complex and mandates precise assessment of the mitral pathology, symptom status of the patient, and ventricular performance (right and left) among other descriptors. It is important for healthcare providers at all levels to be familiar with the clinical picture, diagnosis, disease course, and management of mitral regurgitation.
二尖瓣反流是一种常见的心脏瓣膜疾病。当它由二尖瓣装置本身的病理改变引起时，被定义为原发性二尖瓣反流；当它由左心室结构或功能扭曲导致时，则被定义为继发性二尖瓣反流。尽管二尖瓣反流的诊断和管理严重依赖超声心动图，但人们应该牢记这种方法的注意事项和缺点。临床决策通常侧重于手术指征，但这很复杂，需要精确评估二尖瓣病变、患者的症状状态以及心室功能（左右心室）等其他指标。各级医疗保健提供者熟悉二尖瓣反流的临床表现、诊断、疾病进程和管理非常重要。
